Influence of clinicopathological variables on CYP protein expression in human liver

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 1, 1996, Pages 33-39

  George, Jacob ^a   Byth, Karen ^a   Farrell, Geoffrey C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bilirubin; CYP; CYP1A2; CYP2C8 10; CYP2E1; CYP3A; Cytochrome P450; Human liver; Nutrition

Indexed keywords

ALBUMIN; BILIRUBIN; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME;

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER MICROSOME METABOLISM; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029991247     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00007.x     Document Type: Article

References (35)

1. George J, Murray M, Byth K, Farrell GC. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 1995; 21: 120-8.
2. George J, Byth K, Farrell GC. Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol. 1995 (in press).
3. Wrighton SA, Thomas PE, Molowa DT et al. Characterization of ethanol-inducible human liver N-nitrosodimethylamine demethylase. Biochemistry 1986; 25: 6731-5.
4. Takahashi T, Lasker JM, Rosman AS, Leiber CS. Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 1993; 17: 236-45
5. Combalbert J, Fabre I, Fabre G et al. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily. Drug Metab. Dispos. 1989; 17: 197-207.
6. Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J. Clin. Invest. 1989; 83: 688-97.
7. Diaz D, Fabre I, Daujat M et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 1990; 99: 737-47.
8. Zand R, Nelson SD, Slattery JT et al. Inhibition and induction of cytochrome P4502E1-catalyzed oxidation of isoniazid in humans. Clin. Pharmacol. Ther. 1993; 54: 142-9.
9. Branch RA, Herbert CM, Read AE. Determinants of serum antipyrine half-lives in patients with liver disease. Gut 1973; 14: 569-73.
10. Farrell GC, Cooksley WGE, Hart P, Powell LW. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism. Gastroenterology 1978; 75: 580-8.
11. Sultatos LG, Vesell ES. Enhanced drug-metabolizing capacity within liver adjacent to human and rat liver tumors. Proc. Natl Acad. Sci. USA 1980; 77: 600-3.
12. International Hepatology Informatics Group. Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and prognosis. New York: Raven Press, 1994; 47-164.
13. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
14. Murray M, Zaluzny L, Farrell GC. Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline deficient rat model. Biochem. Pharmacol. 1986; 35: 1817-24.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement by the folin phenol reagent. J. Biol. Chem. 1951; 193: 265-75.
16. Omura T, Sato R. The carbon monoxide binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 1964; 239: 2379-85.
17. Williams CH, Kamin H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J. Biol. Chem. 1962; 237: 187-94.
18. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
19. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl Acad. Sci. USA 1979; 76: 4350-4.
20. George J, Farrell GC. Role of human hepatic cytochromes P450 in drug metabolism and toxicity. Aust. N.Z. J. Med. 1991; 21: 356-62.
21. Ortiz de Montellano PR. Cytochrome P-450: Structure, Mechanism, and Biochemistry. New York: Plenum Press, 1986; 90-125.
22. Stolz A, Kaplowitz N. Biochemical tests for liver disease. In: Zakim D, Boyer TD, eds. Hepatology. A Textbook of Liver Disease, 2nd edn. Philadelphia: WB Saunders, 1990; 637-67.
23. Hong J, Pan J, Gonzalez FJ, Gelboin HV, Yang CS. The induction of a specific form of cytochrome P-450 (P-450j) by fasting. Biochem. Biophys. Res. Commun. 1987; 142: 1077-83.
24. Salazar DE, Sorge CL, Corcoran GB. Obesity as a risk factor for drug-induced organ injury. VI. Increased hepatic P-450 concentration and microsomal ethanol oxidizing activity in the obese overfed rat. Biochem. Biophys. Res. Commun. 1988; 157: 315-20.
25. Raucy JL, Lasker JM, Kraner JC, Salazar DE, Leiber CS, Corcoran GB. Induction of P-450IIE1 in the obese overfed rat. Mol. Pharmacol. 1991; 39: 275-80.
26. Yun Y-P, Casazza JP, Sohn DH, Veech RL, Song BJ. Pretranslational activation of cytochrome P450IIE during ketosis induced by a high fat diet. Mol. Pharmacol. 1992; 41: 474-9.
27. Shanbhogue RL, Bistrian BR, Jenkins RL, Jones C, Benotti P, Backburn GL. Resting energy expenditure in patients with end-stage liver disease. J. Parenter. Enter. Nutr. 1987; 11: 305-8.
28. McCaughan GW, Vidot H, Sheill AG, Gallagher ND, Stewart P. Nutritional assessment of adult patients with end-stage nonalcoholic liver disease. Aust. N.Z. J. Med. 1988; 18: 398 (Abstract).
29. Cabre E, Gonzalez-Huix F, Abad-Lacruz A et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98: 715-20.
30. Schneeweiss B, Graninger W, Ferenci P et al. Energy metabolism in patients with acute and chronic liver disease. Hepatology 1990; 11: 387-93.
31. Silk DB, O'Keefe SJ, Wicks A. Nutritional support in liver disease. Gut 1991; 32 (Suppl 1): S29-33.
32. Crawford DHG, Cuneo RC, Shepherd RW. Pathogenesis and assessment of malnutrition in liver disease. J. Gastroenterol. Hepatol. 1993; 8: 89-94.
33. Abdel-Razzak Z, Loyer P, Fautrel A et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 1993; 44: 707-15.
34. Donato MT, Herrero E, Gomez-Lechon MJ, Castell JV. Inhibition of mono-oxygenase activities in human hepatocytes by interferons. Toxicol. In Vitro 1993; 7: 481-5.
35. Liddle C, Goodwin BJ, George J, Tapner M, Farrell GC. Hormonal factors directly regulate human hepatic CYP3A4 gene expression, J. Gastroenterol. Hepatol. 1994; 9: A99 (Abstract).